Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 4Sarcoma 1Lymphoid 1Gynecologic 1Genitourinary 1Gastrointestinal 1Classical hematology 1Breast 1

Conditions

Drug-Related Side Effects and Adverse Reactions 1Central Nervous System Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

selpercatinib 2Trastuzumab 2Paclitaxel 2sodium thiosulfate 1pazopanib 1glutathione pegylated liposomal doxorubicin 1fluoroacetic acid 1elacestrant 1durvalumab 1carboxyamido-triazole 1abemaciclib 1Temozolomide 1Taxes 1Surveys and Questionnaires 1RAD1901 1Quality of Life 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Methotrexate 1Magnetic Resonance Spectroscopy 1MLN 8237 1Levofloxacin 1Lapatinib 1Immunotherapy 1Immunoenzyme Techniques 1Genetic Testing 1Genetic Counseling 1Gemcitabine 1Drug Therapy 1D-methadone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Central Nervous System Neoplasms × sodium thiosulfate × Breast × Clear all
NCT00397501 2017-04-21

BBBD Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the Brain

OHSU Knight Cancer Institute

Phase 1/2 Withdrawn
BreastCNS

Brain Neoplasms, Breast Neoplasms, Central Nervous System Neoplasms, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡